홀뮴 및 홀뮴-키토산 복합체가 정상 백서 뇌에 미치는 효과에 대한 연구

Effects of 166Holmium and 166Holmium-chitosan Complex(166Ho-CHICO) on Normal Brain of Rats

  • 손경화 (연변대학 의학원 부속병원 신경외과) ;
  • 조철우 (아주대학교 의과대학 신경핵의학교실) ;
  • 안영환 (아주대학교 의과대학 신경외과학교실) ;
  • 박찬희 (아주대학교 의과대학 신경핵의학교실) ;
  • 심철 (아주대학교 의과대학 해부병리학교실) ;
  • 박경배 (한국 원자력 연구소) ;
  • 조경기 (아주대학교 의과대학 신경외과학교실)
  • Sun, Jing He (Department of Neurosurgery, Affiliated Hospital of Yan Bian University Medical College) ;
  • Joh, Chul W (Department of Nuclear Medicine, Ajou University School of Medicine) ;
  • Ahn, Young Hwan (Department of Neurosurgery, Ajou University School of Medicine) ;
  • Park, Chan Hee (Department of Nuclear Medicine, Ajou University School of Medicine) ;
  • Shim, Chull (Department of Pathology, Ajou University School of Medicine) ;
  • Park, Kyung Bae (Korea and Korean Atomic Energy Research Institute) ;
  • Cho, Kyung Gi (Department of Neurosurgery, Ajou University School of Medicine)
  • 투고 : 2000.08.11
  • 심사 : 2001.01.08
  • 발행 : 2000.10.28

초록

Objectives : We performed an in vivo experiment to investigate the effect of $^{166}Holmium$ and $^{166}Holmium$-chitosan complex($^{166}Ho$-CHICO) on the normal brain of rats and to determine the sublethal dose of $^{166}Ho$-CHICO. Materials and Methods : $^{166}Ho$ is a beta and gamma ray emitter. $^{166}Ho$-CHICO is a novel radio-pharmaceutical complex with chitosan to facilitate the transport of $^{166}Ho$ obtained from Korea Atomic Energy Research Center(Taejon, Korea). It is in acidic form and becomes gel state at alkaline pH. One hundred and seventy consecutive rats were divided into four groups : $^{166}Ho$ treated(n=50), $^{166}Ho$-CHICO treated(n=57), saline treated(n=5) and chitosan treated(n=5) groups. $^{166}Ho$ and $^{166}Ho$-CHICO were injected into the rat brain stereotactically with various doses of 0.1mCi/$20{\mu}l$, 0.2mCi/$20{\mu}l$, 0.3mCi/$20{\mu}l$, and 0.4mCi/$20{\mu}l$ using an automated microinjector. Nuclear imaging, histopathological and hematological studies were performed in 10 rats in each group at 1 day, 3days, 7 days, 1 month and 3 months after the injections. Results : An infiltration of inflammatory cells and necrotic changes were noted in $^{166}Ho$ treated group at 1 week after the injection. A wedge-shaped tissue defect due to necrosis, lined with infiltrated glial cells in $^{166}Ho$ treated group and a cystic defect lined with reactive astroglial cells in $^{166}Holmium$-CHICO treated group at 3 months after the injection were observed. $^{166}Ho$ alone without chitosan leaked out and caused necrotic lesion on the cerebral surface but $^{166}Holmium$-CHICO treated group did not show this feature. As the dose of $^{166}Ho$ increased, the mortality rates were also increased. The mortality rate of the $^{166}Holmium$-CHICO group was higher than the $^{166}Ho$ treated group at a dose of 0.4mCi/$20{\mu}l$/300g. There was no detectable radioactivity due to the leakage or extravasation from the injected site of the brain on the scintigraphy performed at 1 hour, 24 hours and 48 hours after the injection. There was also no detectable activity of $^{166}Holmium$-CHICO in other organs including spleen, liver and kidney. Conclusions : $^{166}Ho$-CHICO did not leak out to the critical cortical surface of the brain from the injection site and induced radiation changes of the parenchyma around the injection site without cortical damage. The sublethal dose of $^{166}Ho$-CHICO for the normal brain in rats was determined to be 0.2mCi/$20{\mu}l$/300g.

키워드